A $1 trillion infrastructure program would boost technology companies as well as U.S. builders. Read More

The mail this week covers a diverse range of topics, as usual. Read our take on marijuana stocks, the new space race, toxic energy stocks, and tech sector standouts. Read More

This high yielder's sponsors want out. Read More

In addition to gold funds and mining stocks, the purchase of physical gold has its virtues. Here’s how to do it right. Read More

If Donald Trump imposes a border tax on Mexico, U.S. refiners and natural gas producers aren't going to like it very much. Read More

The virtual and augmented reality revolution is projected to generate annual sales of $108 billion by 2021. Get in the game, with this well-timed play. Read More

The likely defeat of right-wing nationalist Marine Le Pen in France’s presidential election next month is a boon for EU stability and a tailwind for European stocks. Read More

Preventative and self-care products are growing at three times the growth rate of traditional over the counter sick-remedy items. CVS is poised to thrive on the trend. Read More

Lawmakers still haven’t given up trying to replace the Affordable Care Act, but their efforts appear quixotic. Here’s a health care IT stock that actually benefits from the continuing disarray in Washington, DC. Read More

China's demand growth for electric vehicles is impressive, it still isn't going to take a noticeable bite out of oil demand. Read More